Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma - Quiz - MDSpire

Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma

  • By

  • Tim Richardson

  • Hishan Tharmaseelan

  • Lukas Frenzel

  • Philipp Gödel

  • Moritz Fürstenau

  • Pascal Nieper

  • Till Braun

  • Daniel Schütte

  • Michael Hallek

  • Christof Scheid

  • Udo Holtick

  • November 15, 2024

  • 0 min

Share

Original Source(s)

Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma

  • by Tim Richardson, Hishan Tharmaseelan, Lukas Frenzel, Philipp Gödel, Moritz Fürstenau, Pascal Nieper, Till Braun, Daniel Schütte, Michael Hallek, Christof Scheid, Udo Holtick

  • November 15, 2024

Related Content

Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma

Combined chemotherapy with sequential allogeneic hematopoietic stem cell transplantation successfully treats primary plasma cell leukemia: a case report

Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma